annual FCF:
$9.84B+$5.04B(+105.20%)Summary
- As of today (April 24, 2025), PFE annual free cash flow is $9.84 billion, with the most recent change of +$5.04 billion (+105.20%) on December 1, 2024.
- During the last 3 years, PFE annual FCF has fallen by -$20.03 billion (-67.07%).
- PFE annual FCF is now -67.07% below its all-time high of $29.87 billion, reached on December 31, 2021.
Performance
PFE Free cash flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly FCF:
$5.80B-$259.00M(-4.27%)Summary
- As of today (April 24, 2025), PFE quarterly free cash flow is $5.80 billion, with the most recent change of -$259.00 million (-4.27%) on December 1, 2024.
- Over the past year, PFE quarterly FCF has increased by +$5.42 billion (+1403.63%).
- PFE quarterly FCF is now -46.07% below its all-time high of $10.76 billion, reached on June 1, 2021.
Performance
PFE quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM FCF:
$9.84B+$1.61B(+19.55%)Summary
- As of today (April 24, 2025), PFE TTM free cash flow is $9.84 billion, with the most recent change of +$1.61 billion (+19.55%) on December 1, 2024.
- Over the past year, PFE TTM FCF has increased by +$4.73 billion (+92.62%).
- PFE TTM FCF is now -69.06% below its all-time high of $31.78 billion, reached on March 1, 2022.
Performance
PFE TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Free cash flow Formula
FCF = Cash From Operations − CAPEX
PFE Free cash flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +105.2% | +1403.6% | +92.6% |
| 3 y3 years | -67.1% | +1403.6% | +92.6% |
| 5 y5 years | -6.7% | +116.2% | -19.0% |
PFE Free cash flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -67.1% | +105.2% | -23.4% | +340.0% | -69.1% | +105.2% |
| 5 y | 5-year | -67.1% | +105.2% | -46.1% | +340.0% | -69.1% | +105.2% |
| alltime | all time | -67.1% | +7305.9% | -46.1% | +187.1% | -69.1% | >+9999.0% |
Pfizer Free cash flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $9.84B(+105.2%) | $5.80B(-4.3%) | $9.84B(+19.5%) |
| Sep 2024 | - | $6.06B(-350.7%) | $8.23B(+71.0%) |
| Jun 2024 | - | -$2.42B(-726.4%) | $4.81B(-5.8%) |
| Mar 2024 | - | $386.00M(-90.8%) | $5.11B(+6.5%) |
| Dec 2023 | $4.79B(-81.6%) | $4.20B(+58.6%) | $4.79B(-41.4%) |
| Sep 2023 | - | $2.65B(-224.7%) | $8.18B(-23.3%) |
| Jun 2023 | - | -$2.12B(-3006.8%) | $10.66B(-47.2%) |
| Mar 2023 | - | $73.00M(-99.0%) | $20.21B(-22.4%) |
| Dec 2022 | $26.03B(-12.8%) | $7.58B(+47.7%) | $26.03B(+11.4%) |
| Sep 2022 | - | $5.13B(-30.8%) | $23.36B(-17.9%) |
| Jun 2022 | - | $7.42B(+25.8%) | $28.44B(-10.5%) |
| Mar 2022 | - | $5.90B(+20.1%) | $31.78B(+6.4%) |
| Dec 2021 | $29.87B(+145.3%) | $4.91B(-51.9%) | $29.87B(+0.3%) |
| Sep 2021 | - | $10.21B(-5.1%) | $29.77B(+40.8%) |
| Jun 2021 | - | $10.76B(+170.1%) | $21.14B(+56.9%) |
| Mar 2021 | - | $3.98B(-17.2%) | $13.48B(+10.7%) |
| Dec 2020 | $12.18B(+15.5%) | $4.81B(+204.0%) | $12.18B(+11.1%) |
| Sep 2020 | - | $1.58B(-48.9%) | $10.96B(-17.1%) |
| Jun 2020 | - | $3.10B(+15.4%) | $13.22B(+8.9%) |
| Mar 2020 | - | $2.68B(-25.3%) | $12.15B(+15.2%) |
| Dec 2019 | $10.54B(-23.0%) | $3.59B(-6.7%) | $10.54B(-3.8%) |
| Sep 2019 | - | $3.85B(+90.2%) | $10.96B(-7.2%) |
| Jun 2019 | - | $2.02B(+87.3%) | $11.81B(-10.6%) |
| Mar 2019 | - | $1.08B(-73.0%) | $13.21B(-3.5%) |
| Dec 2018 | $13.69B(-6.1%) | $4.01B(-14.7%) | $13.69B(-14.4%) |
| Sep 2018 | - | $4.70B(+37.2%) | $16.00B(+2.6%) |
| Jun 2018 | - | $3.42B(+118.7%) | $15.60B(+4.5%) |
| Mar 2018 | - | $1.56B(-75.2%) | $14.92B(+2.3%) |
| Dec 2017 | $14.59B(+2.8%) | $6.32B(+47.2%) | $14.59B(+7.7%) |
| Sep 2017 | - | $4.29B(+56.0%) | $13.54B(-0.1%) |
| Jun 2017 | - | $2.75B(+124.4%) | $13.55B(-2.6%) |
| Mar 2017 | - | $1.23B(-76.7%) | $13.91B(-2.0%) |
| Dec 2016 | $14.19B(+7.6%) | $5.27B(+22.5%) | $14.19B(+7.9%) |
| Sep 2016 | - | $4.30B(+38.5%) | $13.16B(-2.9%) |
| Jun 2016 | - | $3.11B(+106.3%) | $13.55B(-5.0%) |
| Mar 2016 | - | $1.51B(-64.4%) | $14.27B(+8.1%) |
| Dec 2015 | $13.19B(-14.9%) | $4.24B(-9.8%) | $13.19B(-6.8%) |
| Sep 2015 | - | $4.70B(+22.7%) | $14.16B(+5.9%) |
| Jun 2015 | - | $3.83B(+781.8%) | $13.37B(+0.5%) |
| Mar 2015 | - | $434.00M(-91.7%) | $13.30B(-14.2%) |
| Dec 2014 | $15.50B(-4.4%) | $5.20B(+33.3%) | $15.50B(-0.1%) |
| Sep 2014 | - | $3.90B(+3.8%) | $15.52B(-9.7%) |
| Jun 2014 | - | $3.76B(+42.5%) | $17.19B(+1.8%) |
| Mar 2014 | - | $2.64B(-49.5%) | $16.88B(+4.1%) |
| Dec 2013 | $16.22B(+5.8%) | $5.22B(-6.2%) | $16.22B(+5.6%) |
| Sep 2013 | - | $5.57B(+61.6%) | $15.36B(+5.9%) |
| Jun 2013 | - | $3.45B(+74.5%) | $14.50B(-1.9%) |
| Mar 2013 | - | $1.98B(-54.7%) | $14.78B(-3.6%) |
| Dec 2012 | $15.33B(-16.5%) | $4.36B(-7.5%) | $15.33B(-0.5%) |
| Sep 2012 | - | $4.72B(+26.6%) | $15.41B(+5.0%) |
| Jun 2012 | - | $3.73B(+47.9%) | $14.67B(-11.0%) |
| Mar 2012 | - | $2.52B(-43.3%) | $16.49B(-10.2%) |
| Dec 2011 | $18.36B(+84.7%) | $4.44B(+11.4%) | $18.36B(-6.5%) |
| Sep 2011 | - | $3.98B(-28.1%) | $19.63B(-10.9%) |
| Jun 2011 | - | $5.54B(+26.1%) | $22.04B(+5.0%) |
| Mar 2011 | - | $4.39B(-23.1%) | $21.00B(+111.2%) |
| Dec 2010 | $9.94B(-35.4%) | $5.71B(-10.7%) | $9.94B(+15.2%) |
| Sep 2010 | - | $6.39B(+42.1%) | $8.63B(+42.0%) |
| Jun 2010 | - | $4.50B(-167.5%) | $6.08B(+4.4%) |
| Mar 2010 | - | -$6.67B(-251.4%) | $5.82B(-62.1%) |
| Dec 2009 | $15.38B(-7.0%) | $4.40B(+14.7%) | $15.38B(-7.1%) |
| Sep 2009 | - | $3.84B(-9.5%) | $16.56B(+2.0%) |
| Jun 2009 | - | $4.25B(+46.7%) | $16.23B(-2.5%) |
| Mar 2009 | - | $2.89B(-48.2%) | $16.64B(+0.6%) |
| Dec 2008 | $16.54B(+45.5%) | $5.58B(+59.2%) | $16.54B(+18.6%) |
| Sep 2008 | - | $3.51B(-24.7%) | $13.95B(-4.8%) |
| Jun 2008 | - | $4.66B(+67.0%) | $14.66B(+10.7%) |
| Mar 2008 | - | $2.79B(-6.9%) | $13.24B(+16.5%) |
| Dec 2007 | $11.36B | $2.99B(-29.0%) | $11.36B(-5.9%) |
| Sep 2007 | - | $4.22B(+30.3%) | $12.08B(+6.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2007 | - | $3.24B(+254.2%) | $11.32B(-11.3%) |
| Mar 2007 | - | $914.00M(-75.4%) | $12.76B(-17.1%) |
| Dec 2006 | $15.39B(+21.9%) | $3.71B(+7.2%) | $15.39B(-2.6%) |
| Sep 2006 | - | $3.46B(-25.9%) | $15.80B(+6.4%) |
| Jun 2006 | - | $4.67B(+31.9%) | $14.86B(+10.5%) |
| Mar 2006 | - | $3.54B(-14.1%) | $13.44B(+6.5%) |
| Dec 2005 | $12.63B(-8.1%) | $4.12B(+63.8%) | $12.63B(-5.9%) |
| Sep 2005 | - | $2.52B(-22.7%) | $13.42B(-13.5%) |
| Jun 2005 | - | $3.26B(+19.4%) | $15.51B(+1.0%) |
| Mar 2005 | - | $2.73B(-44.5%) | $15.36B(+11.8%) |
| Dec 2004 | $13.74B(+51.0%) | $4.92B(+6.6%) | $13.74B(+10.4%) |
| Sep 2004 | - | $4.61B(+48.6%) | $12.44B(+23.9%) |
| Jun 2004 | - | $3.10B(+179.2%) | $10.04B(+21.7%) |
| Mar 2004 | - | $1.11B(-69.3%) | $8.25B(-9.3%) |
| Dec 2003 | $9.10B(+8.0%) | $3.62B(+63.3%) | $9.10B(+4.8%) |
| Sep 2003 | - | $2.21B(+69.0%) | $8.68B(+3.1%) |
| Jun 2003 | - | $1.31B(-32.9%) | $8.41B(-8.7%) |
| Mar 2003 | - | $1.96B(-38.8%) | $9.21B(+9.4%) |
| Dec 2002 | $8.43B(+19.2%) | $3.20B(+63.9%) | $8.43B(+19.9%) |
| Sep 2002 | - | $1.95B(-7.6%) | $7.03B(-1.3%) |
| Jun 2002 | - | $2.11B(+81.0%) | $7.12B(+3.9%) |
| Mar 2002 | - | $1.17B(-35.2%) | $6.85B(-3.1%) |
| Dec 2001 | $7.07B(+76.5%) | $1.80B(-11.9%) | $7.07B(-4.4%) |
| Sep 2001 | - | $2.04B(+10.4%) | $7.40B(+5.9%) |
| Jun 2001 | - | $1.85B(+33.5%) | $6.98B(+20.6%) |
| Mar 2001 | - | $1.38B(-34.9%) | $5.79B(+44.6%) |
| Dec 2000 | $4.00B(+34.4%) | $2.13B(+30.8%) | $4.00B(+21.7%) |
| Sep 2000 | - | $1.63B(+148.1%) | $3.29B(+17.1%) |
| Jun 2000 | - | $655.00M(-262.9%) | $2.81B(-8.1%) |
| Mar 2000 | - | -$402.00M(-128.5%) | $3.05B(+2.5%) |
| Dec 1999 | $2.98B(-7.7%) | $1.41B(+23.3%) | $2.98B(-26.9%) |
| Sep 1999 | - | $1.14B(+27.0%) | $4.08B(+20.3%) |
| Jun 1999 | - | $901.00M(-289.3%) | $3.39B(+19.7%) |
| Mar 1999 | - | -$476.00M(-119.0%) | $2.83B(-12.3%) |
| Dec 1998 | $3.23B(+387.9%) | $2.51B(+449.0%) | $3.23B(+270.4%) |
| Sep 1998 | - | $457.00M(+33.2%) | $872.00M(+30.3%) |
| Jun 1998 | - | $343.00M(-534.2%) | $669.00M(+26.9%) |
| Mar 1998 | - | -$79.00M(-152.3%) | $527.00M(-20.4%) |
| Dec 1997 | $662.00M(-19.4%) | $151.00M(-40.6%) | $662.00M(+24.9%) |
| Sep 1997 | - | $254.00M(+26.4%) | $530.00M(-20.7%) |
| Jun 1997 | - | $201.00M(+258.9%) | $668.00M(-15.5%) |
| Mar 1997 | - | $56.00M(+194.7%) | $791.00M(-3.7%) |
| Dec 1996 | $821.00M(-27.0%) | $19.00M(-95.2%) | $821.00M(-34.5%) |
| Sep 1996 | - | $392.00M(+21.0%) | $1.25B(+13.8%) |
| Jun 1996 | - | $324.00M(+276.7%) | $1.10B(+29.7%) |
| Mar 1996 | - | $86.00M(-81.0%) | $849.70M(-24.5%) |
| Dec 1995 | $1.13B(+37.7%) | $451.70M(+88.1%) | $1.13B(+17.1%) |
| Sep 1995 | - | $240.10M(+233.9%) | $960.90M(+2.6%) |
| Jun 1995 | - | $71.90M(-80.1%) | $936.60M(-11.7%) |
| Mar 1995 | - | $361.40M(+25.7%) | $1.06B(+29.9%) |
| Dec 1994 | $817.00M(+29.9%) | $287.50M(+33.2%) | $817.00M(-18.8%) |
| Sep 1994 | - | $215.80M(+9.8%) | $1.01B(+3.9%) |
| Jun 1994 | - | $196.60M(+67.9%) | $967.90M(+14.7%) |
| Mar 1994 | - | $117.10M(-75.4%) | $844.20M(+34.3%) |
| Dec 1993 | $628.80M(+373.5%) | $476.40M(+167.9%) | $628.80M(+121.8%) |
| Sep 1993 | - | $177.80M(+143.9%) | $283.50M(+50.4%) |
| Jun 1993 | - | $72.90M(-174.2%) | $188.50M(+39.2%) |
| Mar 1993 | - | -$98.30M(-175.0%) | $135.40M(+2.0%) |
| Dec 1992 | $132.80M(-47.7%) | $131.10M(+58.3%) | $132.80M(-27.7%) |
| Sep 1992 | - | $82.80M(+318.2%) | $183.80M(+52.8%) |
| Jun 1992 | - | $19.80M(-119.6%) | $120.30M(-37.3%) |
| Mar 1992 | - | -$100.90M(-155.4%) | $191.90M(-24.4%) |
| Dec 1991 | $253.80M(-18.9%) | $182.10M(+843.5%) | $253.80M(-20.8%) |
| Sep 1991 | - | $19.30M(-78.9%) | $320.60M(+16.1%) |
| Jun 1991 | - | $91.40M(-334.4%) | $276.10M(+4.2%) |
| Mar 1991 | - | -$39.00M(-115.7%) | $264.90M(-15.4%) |
| Dec 1990 | $313.00M(+57.0%) | $248.90M(-1087.7%) | $313.00M(+388.3%) |
| Sep 1990 | - | -$25.20M(-131.4%) | $64.10M(-28.2%) |
| Jun 1990 | - | $80.20M(+781.3%) | $89.30M(+881.3%) |
| Mar 1990 | - | $9.10M | $9.10M |
| Dec 1989 | $199.30M | - | - |
FAQ
- What is Pfizer annual free cash flow?
- What is the all time high annual FCF for Pfizer?
- What is Pfizer annual FCF year-on-year change?
- What is Pfizer quarterly free cash flow?
- What is the all time high quarterly FCF for Pfizer?
- What is Pfizer quarterly FCF year-on-year change?
- What is Pfizer TTM free cash flow?
- What is the all time high TTM FCF for Pfizer?
- What is Pfizer TTM FCF year-on-year change?
What is Pfizer annual free cash flow?
The current annual FCF of PFE is $9.84B
What is the all time high annual FCF for Pfizer?
Pfizer all-time high annual free cash flow is $29.87B
What is Pfizer annual FCF year-on-year change?
Over the past year, PFE annual free cash flow has changed by +$5.04B (+105.20%)
What is Pfizer quarterly free cash flow?
The current quarterly FCF of PFE is $5.80B
What is the all time high quarterly FCF for Pfizer?
Pfizer all-time high quarterly free cash flow is $10.76B
What is Pfizer quarterly FCF year-on-year change?
Over the past year, PFE quarterly free cash flow has changed by +$5.42B (+1403.63%)
What is Pfizer TTM free cash flow?
The current TTM FCF of PFE is $9.84B
What is the all time high TTM FCF for Pfizer?
Pfizer all-time high TTM free cash flow is $31.78B
What is Pfizer TTM FCF year-on-year change?
Over the past year, PFE TTM free cash flow has changed by +$4.73B (+92.62%)